Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease
This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and t...
Saved in:
Published in | mSystems Vol. 10; no. 4; p. e0114824 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
22.04.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 2379-5077 2379-5077 |
DOI | 10.1128/msystems.01148-24 |
Cover
Abstract | This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD. |
---|---|
AbstractList | ABSTRACTThe development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD. The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6-16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified and as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography ( ) values (≥6.2 kPa) showed an increased abundance of , which was positively correlated with the levels of deoxycholic acid (DCA) and values. Importantly, the mediation analysis identified positive associations between and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that may serve as a novel clinical target in pediatric MASLD. ABSTRACT The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD. The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD. The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6-16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD.The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6-16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography (E) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques, which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management.IMPORTANCEThis study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD. The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut microbiota. This study aims to investigate changes in the gut microbiota signature and microbial metabolites in children with MASLD. We collected fecal samples from children and adolescents aged 6–16 years, and the presence of MASLD was diagnosed by ultrasound. We performed 16S ribosomal DNA sequencing and targeted metabolomics in 36 and 25 subjects, consisting of healthy controls, children with obesity, and children with MASLD. The α-diversity was significantly lower in children with obesity and MASLD compared with healthy controls. Linear discriminant analysis of effect size analysis identified Anaerostipes and A. hadrus as the top biomarkers differentiating the obesity group from the MASLD group. In MASLD patients with high alanine aminotransferase values (≥50 U/L for boys and 44 U/L for girls), we observed a decrease in the gut microbiota health index. MASLD patients with high shear wave elastography ( E ) values (≥6.2 kPa) showed an increased abundance of Ruminococcus torques , which was positively correlated with the levels of deoxycholic acid (DCA) and E values. Importantly, the mediation analysis identified positive associations between R. torques and clinical indicators of MASLD that were mediated by DCA. Overall, our study suggests that gut microbiota and metabolites are significantly altered in children with MASLD, and targeting R. torques may offer potential benefits for disease management. This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver disease (MASLD). We found that an increased abundance of Ruminococcus torques was associated with increased levels of deoxycholic acid and the progression of MASLD, suggesting that R. torques may serve as a novel clinical target in pediatric MASLD. |
Author | Du, Landuoduo Zhang, Huiwen Lu, Deyun Zhou, Yongchang Fan, Jiangao Wang, Ying Zhang, Kaichuang Liang, Lili Ren, Tianyi Jiang, Lu Yang, Yi |
Author_xml | – sequence: 1 givenname: Landuoduo orcidid: 0009-0000-9120-441X surname: Du fullname: Du, Landuoduo – sequence: 2 givenname: Kaichuang surname: Zhang fullname: Zhang, Kaichuang – sequence: 3 givenname: Lili surname: Liang fullname: Liang, Lili – sequence: 4 givenname: Yi surname: Yang fullname: Yang, Yi – sequence: 5 givenname: Deyun surname: Lu fullname: Lu, Deyun – sequence: 6 givenname: Yongchang surname: Zhou fullname: Zhou, Yongchang – sequence: 7 givenname: Tianyi surname: Ren fullname: Ren, Tianyi – sequence: 8 givenname: Jiangao surname: Fan fullname: Fan, Jiangao – sequence: 9 givenname: Huiwen surname: Zhang fullname: Zhang, Huiwen – sequence: 10 givenname: Ying orcidid: 0000-0001-5587-7772 surname: Wang fullname: Wang, Ying – sequence: 11 givenname: Lu orcidid: 0000-0003-4522-3614 surname: Jiang fullname: Jiang, Lu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40084870$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kk9vFSEUxYmpsbX2A7gxJG7czBMYGJiVMY1_mtS40TVh4M57vDBDBabN2_vBpX3tszVxBeH8ODk397xER3OcAaHXlKwoZer9lHe5wJRXhFKuGsafoRPWyr4RRMqjR_djdJbzlhBCu1ZS1r9Ax5wQxZUkJ-j3tyUU38TJ24zNbMIuQ8ZxxGUDeL0UXIUUBx-LqbLDExQzxOBLpfyM7cYHl2DGN75sDqLFbpfHZbbFx7kxOUfrTQGHa2BTYqlA8NeQsPMZTIZX6PloQoaz-_MU_fz86cf51-by-5eL84-XjalhS-Ng5E4RNSoySOU6UQcSIwEnesla0o-GOMcpCFdH69oehFWqZ1xBL5zsWHuKLva-Lpqtvkp-Mmmno_H67iGmtTappgugLSPCWmWcIJZ3vFWcDYPrpBgHYrvh1uvD3utqGSZwFuaSTHhi-lSZ_Uav47WmjNCWSVEd3t07pPhrgVz05LOFEMwMccm6pVJS0SlGK_r2H3Qbl1S3VSlGOOuV7LpKrfaUyRP7S1CibwujHwqj7wqjGa8f3jye4RD-oR4VoHugdiDnBOMB-b_pH2AF0wM |
Cites_doi | 10.1002/hep.28572 10.1126/sciadv.abg3750 10.1097/MPG.0000000000001482 10.1053/j.gastro.2019.06.028 10.1128/jb.173.2.697-703.1991 10.1038/srep27572 10.1099/00207713-44-4-846 10.1016/j.cell.2016.05.041 10.1038/ajg.2010.281 10.1038/s41467-017-00796-x 10.1097/HC9.0000000000000310 10.1002/hep.26093 10.1186/gb-2011-12-6-r60 10.3389/fmicb.2021.728823 10.1021/acs.analchem.0c04686 10.1038/s41467-020-18476-8 10.1016/j.cmet.2019.08.002 10.1016/j.hbpd.2023.06.006 10.1053/j.gastro.2020.07.005 10.1038/s41467-019-13036-1 10.1038/nmeth.2604 10.1186/s12944-021-01440-w 10.1038/s41575-019-0169-z 10.1128/spectrum.05230-22 10.3390/metabo13101043 10.1148/radiol.14131251 10.3390/cancers12092619 10.2471/blt.07.043497 10.1016/j.jhepr.2021.100387 10.1136/gut.2010.223263 10.1038/s41575-020-0269-9 10.1111/liv.15852 10.1097/HEP.0000000000000520 10.1016/j.cell.2024.02.022 10.1016/j.clnu.2023.11.001 10.1038/s41467-023-36256-y |
ContentType | Journal Article |
Copyright | Copyright © 2025 Du et al. Copyright © 2025 Du et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2025 Du et al. 2025 Du et al. |
Copyright_xml | – notice: Copyright © 2025 Du et al. – notice: Copyright © 2025 Du et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2025 Du et al. 2025 Du et al. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1128/msystems.01148-24 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Biological Science Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2379-5077 |
Editor | Das, Promi |
Editor_xml | – sequence: 1 givenname: Promi surname: Das fullname: Das, Promi |
ExternalDocumentID | oai_doaj_org_article_c205cc8ad50c4643842bbd675fb0c6b2 PMC12013275 msystems01148-24 40084870 10_1128_msystems_01148_24 |
Genre | Journal Article |
GeographicLocations | United States--US China Shanghai China |
GeographicLocations_xml | – name: Shanghai China – name: China – name: United States--US |
GrantInformation_xml | – fundername: MOST | National Key Research and Development Program of China (NKPs) grantid: 2022YFA1305600 – fundername: STCSM | Natural Science Foundation of Shanghai Municipality () grantid: 23ZR1452600 – fundername: Shanghai Municipal Health Commission () grantid: 20234Z0004 – fundername: STCSM | Natural Science Foundation of Shanghai Municipality () grantid: 22ZR1441100 – fundername: MOST | National Natural Science Foundation of China (NSFC) grantid: 82100950 – fundername: STCSM | Natural Science Foundation of Shanghai Municipality (上海市自然科学基金) grantid: 22ZR1441100 – fundername: STCSM | Natural Science Foundation of Shanghai Municipality (上海市自然科学基金) grantid: 23ZR1452600 – fundername: Shanghai Municipal Health Commission (上海市卫生健康委员会) grantid: 20234Z0004 – fundername: ; grantid: 23ZR1452600 – fundername: ; grantid: 2022YFA1305600 – fundername: ; grantid: 20234Z0004 – fundername: ; grantid: 82100950 – fundername: ; grantid: 22ZR1441100 |
GroupedDBID | 0R~ 53G 5VS 7X7 8FE 8FH 8FI 8FJ AAFWJ AAGFI AAUOK AAYXX ABUWG ACPRK ADBBV AFKRA AFPKN AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION EBS FRP FYUFA GROUPED_DOAJ H13 HCIFZ HMCUK HYE KQ8 LK8 M48 M7P M~E O9- OK1 PHGZM PHGZT PIMPY PQGLB PQQKQ PROAC PUEGO RHI RPM RSF UKHRP ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-a487t-def4d808f80b78d651635f0ed5972309fa0dd41e5d870639e5c889248e95d7623 |
IEDL.DBID | M48 |
ISSN | 2379-5077 |
IngestDate | Wed Aug 27 01:24:13 EDT 2025 Thu Aug 21 18:26:59 EDT 2025 Thu Sep 04 17:52:52 EDT 2025 Fri Jul 25 09:18:37 EDT 2025 Tue Apr 22 18:20:29 EDT 2025 Fri Apr 25 03:24:40 EDT 2025 Wed Sep 10 05:25:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | deoxycholic acid biomarker steatosis Ruminococcus torques pediatric |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a487t-def4d808f80b78d651635f0ed5972309fa0dd41e5d870639e5c889248e95d7623 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Landuoduo Du and Kaichuang Zhang contributed equally to this article. Author order was determined based on the extent of their individual contributions to the different sections of the research and the manuscript preparation. The authors declare no conflict of interest. |
ORCID | 0000-0001-5587-7772 0000-0003-4522-3614 0009-0000-9120-441X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1128/msystems.01148-24 |
PMID | 40084870 |
PQID | 3204298766 |
PQPubID | 2045591 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c205cc8ad50c4643842bbd675fb0c6b2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12013275 proquest_miscellaneous_3177156821 proquest_journals_3204298766 asm2_journals_10_1128_msystems_01148_24 pubmed_primary_40084870 crossref_primary_10_1128_msystems_01148_24 |
PublicationCentury | 2000 |
PublicationDate | 2025-04-22 |
PublicationDateYYYYMMDD | 2025-04-22 |
PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC – name: Washington |
PublicationTitle | mSystems |
PublicationTitleAbbrev | mSystems |
PublicationTitleAlternate | mSystems |
PublicationYear | 2025 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_4_3_2 e_1_3_4_2_2 e_1_3_4_9_2 e_1_3_4_8_2 e_1_3_4_7_2 e_1_3_4_6_2 e_1_3_4_5_2 e_1_3_4_4_2 e_1_3_4_22_2 e_1_3_4_23_2 e_1_3_4_20_2 e_1_3_4_21_2 e_1_3_4_26_2 e_1_3_4_27_2 e_1_3_4_24_2 e_1_3_4_25_2 e_1_3_4_28_2 e_1_3_4_29_2 e_1_3_4_30_2 e_1_3_4_11_2 e_1_3_4_34_2 e_1_3_4_12_2 e_1_3_4_33_2 e_1_3_4_32_2 e_1_3_4_10_2 e_1_3_4_31_2 e_1_3_4_15_2 e_1_3_4_38_2 e_1_3_4_16_2 e_1_3_4_37_2 e_1_3_4_13_2 e_1_3_4_36_2 e_1_3_4_14_2 e_1_3_4_35_2 e_1_3_4_19_2 e_1_3_4_17_2 e_1_3_4_18_2 B21 de Onis, M, Onyango, AW, Borghi, E, Siyam, A, Nishida, C, Siekmann, J (B9) 2007; 85 Wang, T, Guo, XK, Xu, H (B34) 2021; 12 Xie, G, Wang, L, Chen, T, Zhou, K, Zhang, Z, Li, J, Sun, B, Guo, Y, Wang, X, Wang, Y, Zhang, H, Liu, P, Nicholson, JK, Ge, W, Jia, W (B17) 2021; 93 Zhu, L, Baker, SS, Gill, C, Liu, W, Alkhouri, R, Baker, RD, Gill, SR (B8) 2013; 57 Deng, K, Xu, JJ, Shen, L, Zhao, H, Gou, W, Xu, F, Fu, Y, Jiang, Z, Shuai, M, Li, BY, Hu, W, Zheng, JS, Chen, YM (B16) 2023; 14 Png, CW, Lindén, SK, Gilshenan, KS, Zoetendal, EG, McSweeney, CS, Sly, LI, McGuckin, MA, Florin, THJ (B18) 2010; 105 Rinella, ME, Lazarus, JV, Ratziu, V, Francque, SM, Sanyal, AJ, Kanwal, F, Romero, D, Abdelmalek, MF, Anstee, QM, Arab, JP (B2) 2023; 78 Younossi, ZM, Golabi, P, Paik, J, Owrangi, S, Yilmaz, Y, El-Kassas, M, Alswat, K, Alqahtani, SA (B1) 2024; 44 Gillard, J, Clerbaux, LA, Nachit, M, Sempoux, C, Staels, B, Bindels, LB, Tailleux, A, Leclercq, IA (B36) 2022; 4 Nobili, V, Alisi, A, Valenti, L, Miele, L, Feldstein, AE, Alkhouri, N (B3) 2019; 16 Gunathilake, M, Lee, J, Choi, IJ, Kim, YI, Yoon, J, Sul, WJ, Kim, JF, Kim, J (B23) 2020; 12 Del Chierico, F, Nobili, V, Vernocchi, P, Russo, A, De Stefanis, C, Gnani, D, Furlanello, C, Zandonà, A, Paci, P, Capuani, G, Dallapiccola, B, Miccheli, A, Alisi, A, Putignani, L (B7) 2017; 65 Edgar, RC (B14) 2013; 10 Suh, CH, Kim, SY, Kim, KW, Lim, YS, Lee, SJ, Lee, MG, Lee, J, Lee, SG, Yu, E (B26) 2014; 271 Xu, J, Zhou, Y, Cheng, S, Zhao, Y, Yan, J, Wang, Y, Cai, W, Jiang, L (B20) 2023; 13 Lang, S, Demir, M, Martin, A, Jiang, L, Zhang, X, Duan, Y, Gao, B, Wisplinghoff, H, Kasper, P, Roderburg, C, Tacke, F, Steffen, HM, Goeser, T, Abraldes, JG, Tu, XM, Loomba, R, Stärkel, P, Pride, D, Fouts, DE, Schnabl, B (B10) 2020; 159 Luo, J, Luo, M, Kaminga, AC, Wei, J, Dai, W, Peng, Y, Zhao, K, Duan, Y, Xiao, X, Ouyang, S, Yao, Z, Liu, Y, Pan, X (B5) 2024; 12 Loomba, R, Seguritan, V, Li, W, Long, T, Klitgord, N, Bhatt, A, Dulai, PS, Caussy, C, Bettencourt, R, Highlander, SK, Jones, MB, Sirlin, CB, Schnabl, B, Brinkac, L, Schork, N, Chen, CH, Brenner, DA, Biggs, W, Yooseph, S, Venter, JC, Nelson, KE (B30) 2019; 30 Zhang, Q, Wu, Y, Wang, J, Wu, G, Long, W, Xue, Z, Wang, L, Zhang, X, Pang, X, Zhao, Y, Zhao, L, Zhang, C (B33) 2016; 6 Weisburg, WG, Barns, SM, Pelletier, DA, Lane, DJ (B11) 1991; 173 Long, Q, Luo, F, Li, B, Li, Z, Guo, Z, Chen, Z, Wu, W, Hu, M (B29) 2024; 8 Schwimmer, JB, Johnson, JS, Angeles, JE, Behling, C, Belt, PH, Borecki, I, Bross, C, Durelle, J, Goyal, NP, Hamilton, G, Holtz, ML, Lavine, JE, Mitreva, M, Newton, KP, Pan, A, Simpson, PM, Sirlin, CB, Sodergren, E, Tyagi, R, Yates, KP, Weinstock, GM, Salzman, NH (B6) 2019; 157 Johnson, JS, Spakowicz, DJ, Hong, B-Y, Petersen, LM, Demkowicz, P, Chen, L, Leopold, SR, Hanson, BM, Agresta, HO, Gerstein, M, Sodergren, E, Weinstock, GM (B12) 2019; 10 Joossens, M, Huys, G, Cnockaert, M, De Preter, V, Verbeke, K, Rutgeerts, P, Vandamme, P, Vermeire, S (B37) 2011; 60 Wu, MY, Fan, JG (B27) 2023; 22 Aron-Wisnewsky, J, Vigliotti, C, Witjes, J, Le, P, Holleboom, AG, Verheij, J, Nieuwdorp, M, Clément, K (B4) 2020; 17 Segata, N, Izard, J, Waldron, L, Gevers, D, Miropolsky, L, Garrett, WS, Huttenhower, C (B24) 2011; 12 Gupta, VK, Kim, M, Bakshi, U, Cunningham, KY, Davis, JM, Lazaridis, KN, Nelson, H, Chia, N, Sung, J (B22) 2020; 11 Wu, R, Guo, W, Qiu, X, Wang, S, Sui, C, Lian, Q, Wu, J, Shan, Y, Yang, Z, Yang, S (B35) 2021; 7 Koh, A, De Vadder, F, Kovatcheva-Datchary, P, Bäckhed, F (B32) 2016; 165 Li, F, Ye, J, Shao, C, Zhong, B (B28) 2021; 20 Llorente, C, Jepsen, P, Inamine, T, Wang, L, Bluemel, S, Wang, HJ, Loomba, R, Bajaj, JS, Schubert, ML, Sikaroodi, M, Gillevet, PM, Xu, J, Kisseleva, T, Ho, SB, DePew, J, Du, X, Sørensen, HT, Vilstrup, H, Nelson, KE, Brenner, DA, Fouts, DE, Schnabl, B (B19) 2017; 8 Stackebrandt, E, Goebel, BM (B15) 1994; 44 Jia, D, Wang, Q, Qi, Y, Jiang, Y, He, J, Lin, Y, Sun, Y, Xu, J, Chen, W, Fan, L, Yan, R, Zhang, W, Ren, G, Xu, C, Ge, Q, Wang, L, Liu, W, Xu, F, Wu, P, Wang, Y, Chen, S, Wang, L (B13) 2024; 187 Vos, MB, Abrams, SH, Barlow, SE, Caprio, S, Daniels, SR, Kohli, R, Mouzaki, M, Sathya, P, Schwimmer, JB, Sundaram, SS, Xanthakos, SA (B25) 2017; 64 Ji, J, Sun, J, Li, J, Xie, J, Xi, B, Zhao, M (B31) 2024; 43 |
References_xml | – ident: e_1_3_4_8_2 doi: 10.1002/hep.28572 – ident: e_1_3_4_36_2 doi: 10.1126/sciadv.abg3750 – ident: e_1_3_4_26_2 doi: 10.1097/MPG.0000000000001482 – ident: e_1_3_4_7_2 doi: 10.1053/j.gastro.2019.06.028 – ident: e_1_3_4_12_2 doi: 10.1128/jb.173.2.697-703.1991 – ident: e_1_3_4_34_2 doi: 10.1038/srep27572 – ident: e_1_3_4_16_2 doi: 10.1099/00207713-44-4-846 – ident: e_1_3_4_33_2 doi: 10.1016/j.cell.2016.05.041 – ident: e_1_3_4_19_2 doi: 10.1038/ajg.2010.281 – ident: e_1_3_4_20_2 doi: 10.1038/s41467-017-00796-x – ident: e_1_3_4_30_2 doi: 10.1097/HC9.0000000000000310 – ident: e_1_3_4_9_2 doi: 10.1002/hep.26093 – ident: e_1_3_4_25_2 doi: 10.1186/gb-2011-12-6-r60 – ident: e_1_3_4_35_2 doi: 10.3389/fmicb.2021.728823 – ident: e_1_3_4_18_2 doi: 10.1021/acs.analchem.0c04686 – ident: e_1_3_4_22_2 – ident: e_1_3_4_23_2 doi: 10.1038/s41467-020-18476-8 – ident: e_1_3_4_31_2 doi: 10.1016/j.cmet.2019.08.002 – ident: e_1_3_4_28_2 doi: 10.1016/j.hbpd.2023.06.006 – ident: e_1_3_4_11_2 doi: 10.1053/j.gastro.2020.07.005 – ident: e_1_3_4_13_2 doi: 10.1038/s41467-019-13036-1 – ident: e_1_3_4_15_2 doi: 10.1038/nmeth.2604 – ident: e_1_3_4_29_2 doi: 10.1186/s12944-021-01440-w – ident: e_1_3_4_4_2 doi: 10.1038/s41575-019-0169-z – ident: e_1_3_4_6_2 doi: 10.1128/spectrum.05230-22 – ident: e_1_3_4_21_2 doi: 10.3390/metabo13101043 – ident: e_1_3_4_27_2 doi: 10.1148/radiol.14131251 – ident: e_1_3_4_24_2 doi: 10.3390/cancers12092619 – ident: e_1_3_4_10_2 doi: 10.2471/blt.07.043497 – ident: e_1_3_4_37_2 doi: 10.1016/j.jhepr.2021.100387 – ident: e_1_3_4_38_2 doi: 10.1136/gut.2010.223263 – ident: e_1_3_4_5_2 doi: 10.1038/s41575-020-0269-9 – ident: e_1_3_4_2_2 doi: 10.1111/liv.15852 – ident: e_1_3_4_3_2 doi: 10.1097/HEP.0000000000000520 – ident: e_1_3_4_14_2 doi: 10.1016/j.cell.2024.02.022 – ident: e_1_3_4_32_2 doi: 10.1016/j.clnu.2023.11.001 – ident: e_1_3_4_17_2 doi: 10.1038/s41467-023-36256-y – volume: 64 start-page: 319 year: 2017 end-page: 334 ident: B25 article-title: NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children publication-title: J Pediatr Gastroenterol Nutr doi: 10.1097/MPG.0000000000001482 – volume: 8 start-page: 1 year: 2024 ident: B29 article-title: Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease publication-title: Hepatol Commun doi: 10.1097/HC9.0000000000000310 – volume: 12 year: 2024 ident: B5 article-title: Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children publication-title: Microbiol Spectr doi: 10.1128/spectrum.05230-22 – volume: 78 start-page: 1966 year: 2023 end-page: 1986 ident: B2 article-title: A multisociety Delphi consensus statement on new fatty liver disease nomenclature publication-title: Hepatology doi: 10.1097/HEP.0000000000000520 – volume: 13 start-page: 1043 year: 2023 ident: B20 article-title: Lactobacillus johnsonii attenuates liver steatosis and bile acid dysregulation in parenteral nutrition-fed rats publication-title: Metabolites doi: 10.3390/metabo13101043 – volume: 12 start-page: 728823 year: 2021 ident: B34 article-title: Disentangling the progression of non-alcoholic fatty liver disease in the human gut microbiota publication-title: Front Microbiol doi: 10.3389/fmicb.2021.728823 – volume: 159 start-page: 1839 year: 2020 end-page: 1852 ident: B10 article-title: Intestinal virome signature associated with severity of nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.07.005 – volume: 17 start-page: 279 year: 2020 end-page: 297 ident: B4 article-title: Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-020-0269-9 – volume: 165 start-page: 1332 year: 2016 end-page: 1345 ident: B32 article-title: From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites publication-title: Cell doi: 10.1016/j.cell.2016.05.041 – volume: 85 start-page: 660 year: 2007 end-page: 667 ident: B9 article-title: Development of a WHO growth reference for school-aged children and adolescents publication-title: Bull World Health Organ doi: 10.2471/blt.07.043497 – volume: 173 start-page: 697 year: 1991 end-page: 703 ident: B11 article-title: 16S ribosomal DNA amplification for phylogenetic study publication-title: J Bacteriol doi: 10.1128/jb.173.2.697-703.1991 – volume: 11 year: 2020 ident: B22 article-title: A predictive index for health status using species-level gut microbiome profiling publication-title: Nat Commun doi: 10.1038/s41467-020-18476-8 – volume: 157 start-page: 1109 year: 2019 end-page: 1122 ident: B6 article-title: Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.06.028 – volume: 93 start-page: 5709 year: 2021 end-page: 5717 ident: B17 article-title: A metabolite array technology for precision medicine publication-title: Anal Chem doi: 10.1021/acs.analchem.0c04686 – volume: 271 start-page: 895 year: 2014 end-page: 900 ident: B26 article-title: Determination of normal hepatic elasticity by using real-time shear-wave elastography publication-title: Radiology doi: 10.1148/radiol.14131251 – volume: 22 start-page: 444 year: 2023 end-page: 451 ident: B27 article-title: Gut microbiome and nonalcoholic fatty liver disease publication-title: Hepatobiliary Pancreat Dis Int doi: 10.1016/j.hbpd.2023.06.006 – volume: 57 start-page: 601 year: 2013 end-page: 609 ident: B8 article-title: Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH publication-title: Hepatology doi: 10.1002/hep.26093 – volume: 44 start-page: 1061 year: 2024 end-page: 1070 ident: B1 article-title: Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa publication-title: Liver Int doi: 10.1111/liv.15852 – volume: 12 year: 2011 ident: B24 article-title: Metagenomic biomarker discovery and explanation publication-title: Genome Biol doi: 10.1186/gb-2011-12-6-r60 – volume: 44 start-page: 846 year: 1994 end-page: 849 ident: B15 article-title: Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology publication-title: Int J Syst Evol Microbiol doi: 10.1099/00207713-44-4-846 – volume: 7 year: 2021 ident: B35 article-title: Comprehensive analysis of spatial architecture in primary liver cancer publication-title: Sci Adv doi: 10.1126/sciadv.abg3750 – volume: 6 start-page: 27572 year: 2016 ident: B33 article-title: Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium publication-title: Sci Rep doi: 10.1038/srep27572 – volume: 43 start-page: 187 year: 2024 end-page: 196 ident: B31 article-title: Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children publication-title: Clin Nutr doi: 10.1016/j.clnu.2023.11.001 – volume: 10 start-page: 996 year: 2013 end-page: 998 ident: B14 article-title: UPARSE: highly accurate OTU sequences from microbial amplicon reads publication-title: Nat Methods doi: 10.1038/nmeth.2604 – volume: 105 start-page: 2420 year: 2010 end-page: 2428 ident: B18 article-title: Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria publication-title: Am J Gastroenterol doi: 10.1038/ajg.2010.281 – volume: 12 year: 2020 ident: B23 article-title: Alterations in gastric microbial communities are associated with risk of gastric cancer in a korean population: a case-control study publication-title: Cancers (Basel) doi: 10.3390/cancers12092619 – volume: 20 year: 2021 ident: B28 article-title: Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis publication-title: Lipids Health Dis doi: 10.1186/s12944-021-01440-w – volume: 187 start-page: 1651 year: 2024 end-page: 1665 ident: B13 article-title: Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer publication-title: Cell doi: 10.1016/j.cell.2024.02.022 – volume: 16 start-page: 517 year: 2019 end-page: 530 ident: B3 article-title: NAFLD in children: new genes, new diagnostic modalities and new drugs publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0169-z – volume: 14 year: 2023 ident: B16 article-title: Comparison of fecal and blood metabolome reveals inconsistent associations of the gut microbiota with cardiometabolic diseases publication-title: Nat Commun doi: 10.1038/s41467-023-36256-y – volume: 4 year: 2022 ident: B36 article-title: Bile acids contribute to the development of non-alcoholic steatohepatitis in mice publication-title: JHEP Rep doi: 10.1016/j.jhepr.2021.100387 – volume: 60 start-page: 631 year: 2011 end-page: 637 ident: B37 article-title: Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives publication-title: Gut doi: 10.1136/gut.2010.223263 – volume: 8 year: 2017 ident: B19 article-title: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus publication-title: Nat Commun doi: 10.1038/s41467-017-00796-x – ident: B21 article-title: Oksanen J , Simpson G , Blanchet FG , Kindt R , Legendre P , Minchin P , Hara R , Solymos P , Stevens H , Szöcs E , Wagner H , Barbour M , Bedward M , Bolker B , Borcard D , Carvalho G , Chirico M , De Cáceres M , Durand S . 2022 . Vegan community ecology package version 2.6-2 April 2022 – volume: 65 start-page: 451 year: 2017 end-page: 464 ident: B7 article-title: Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach publication-title: Hepatology doi: 10.1002/hep.28572 – volume: 10 start-page: 5029 year: 2019 ident: B12 article-title: Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis publication-title: Nat Commun doi: 10.1038/s41467-019-13036-1 – volume: 30 start-page: 607 year: 2019 ident: B30 article-title: Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease publication-title: Cell Metab doi: 10.1016/j.cmet.2019.08.002 |
SSID | ssj0001637129 |
Score | 2.2956638 |
Snippet | This study investigated alterations in the gut microbiota signature and microbial metabolites in children with metabolic dysfunction-associated steatotic liver... The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut... ABSTRACTThe development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut... ABSTRACT The development and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children are closely related to alterations of gut... |
SourceID | doaj pubmedcentral proquest asm2 pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e0114824 |
SubjectTerms | Adolescent Alanine transaminase biomarker Biomarkers - metabolism Body mass index Case-Control Studies Child Children Children & youth Clinical Microbiology Deoxycholic acid DNA sequencing Fatty Liver - metabolism Fatty Liver - microbiology Feces Feces - microbiology Female Gastrointestinal Microbiome Gut microbiota Homogenization Humans Intestinal microflora Liver diseases Male Metabolism Metabolites Metabolomics Metabolomics - methods Microbiota Multiomics Non-alcoholic Fatty Liver Disease - metabolism Non-alcoholic Fatty Liver Disease - microbiology Obesity Patients pediatric Pediatrics Research Article Ribosomal DNA Ruminococcus Ruminococcus torques Software steatosis Taxonomy Variance analysis |
SummonAdditionalLinks | – databaseName: American Society for Microbiology Open Access dbid: AAUOK link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_OPQRfxG97nhJBEIScaZo06eMqHoeivrhwbyVf1YXbrtjuw73fH-4k_ThXDvG1k9Ihv5nMTCczA_DKKJcHYxy1QRoqhC2orhxGrU1ubK4KYUwsFP78pTxbiY_n8vwAyqkWZtzB7sR0m5TInzWb67ebobtxd5K8eMrFLTiUaK_EAg6Xy9XXT9d_V8pCoSUb05g3votnMH6D79mj1Lb_Jl_z7yuTf9ig03twd3QeyXJA-z4chPYB3B7GSV4-hKtUTUtjnXFHTOo2EjqybQg6eeT7rieb9dB2qTdI9mQTehSBWITckXVLprpuEv_NzkRH_GUXrV9EkJoRzeBJFI9-i5yQi3i3g4ypnkewOv3w7f0ZHacsUIPBSk99aITXTDeaWaV9KXHvZMOCl3EgGasaw7wXeZA-pkSLKkinNUZtOlTS41FaPIZFu23DUyC6YpUK6MLlPja1USYPmqmgrciVKWWRweu45fUEcp0iEK7rCZw6gVNzkcGbCZX659B241-L30Xc5oWxY3Z6gPJTjwpYO86kc9p4yZxAN0wLbq3HcKmxzJWWZ3A8oX7NX8GjvUaDUWbwciajAsasimnDdodrcqUwCNY8z-DJICQzJyKNK1AsA70nPnus7lPa9Y_U5DvnMQum5NF_79kzuMPjcGImKOfHsOh_7cJz9Jh6-2JUj99-HBgb priority: 102 providerName: American Society for Microbiology – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_lgdCL-FHr1loiFAQhNskmm-xRi6UIemqhtyVfqw98-8Tdd-i9f7gz2X2v7xXRi9edHGYzk8xMZuY3hJw6E0RyLjCftGNK-ZLZOkDU2grnhSmVc9go_OVrdXmtPt_om61RX1gTNsIDjxt3FiTXIVgXNQ8KzKdV0vsIbm7reah8vn15zbeCqfy6UpUGLNmUxoQ7-GwxIiP373MEwLDDfeb6hdyxRxm2_0--5sOSyS0bdPGEPJ6cR_phZPop2UvdM_JoHCd5-5zc5W5ahn3GPXUZbST1dNlScPLot9VAF_MRdmlwQI50kQZQAWxC7um8o-u-bopvsxtioPG2R-uHEmRukmaKFNVjWAIn9AfWdtAp1XNAri8-XZ1fsmnKAnMQrAwsplZFy21ruTc2Vhr2Trc8RY0DyXjdOh6jEklHTImWddLBWojabKp1hKu0fEFm3bJLLwm1Na9NAhdORAS1MU4ky02yXgnjKl0W5C1ueTMdk77JEYi0zVo4TRZOI1VB3q2l0vwcYTf-tvgjym2zEBGz8wfQo2bSo-ZfelSQ47XU7_krJdprMBhVQd5syHAAMaviurRcwRphDATBVoqCHI5KsuFE5XEFhhfE7qjPDqu7lG7-PYN8C4lZMKOP_sfPvSL7EucWc8WkPCaz4dcqvQZnavAn-dz8BukaIM0 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Ni9UwMOhbBC_it9VVIgiCEDdNkyY9iSu7LIKLiAt7K2mSrg987brtO-zdH-5Mmr7nE9lrZw5D53smM0PIG6tdHqx1rAnKMimbgpnKQdba5rbJdSGtxUHhL6flyZn8fK7OU8FtSM8qZ5sYDbXvHdbIDwqBphN0t_xw-Yvh1SjsrqYTGrfJHphgA3K-d3h0-vXbtspSFho8WmpnAsrBatqQPLyPmQDDSfeFHVZixy_F9f3_izn_fTr5ly86vk_upSCSfpy4_oDcCt1Dcmc6K3n9iPyOU7UM540HauPWkTDQvqUQ7NGL9UhXy2n90mgB7OkqjCAKOIw80GVH5_luijXaDdBRfz2gF0ROMpu4GjxFMRl7oIT-xDceNLV8HpOz46Pvn05YurbALCQtI_Ohld5w0xreaONLBf9OtTx4hYfJeNVa7r3Mg_LYGi2qoJwxkL2ZUCkPJrV4QhZd34VnhJqKVzpAKJd7XG6jbR4M18E0Mte2VEVG3uIvr5O6DHXMRISpZ-bUkTm1kBl5N3OlvpzWb9yEfIh82yDi5uz4ob-6qJMi1k5w5ZyxXnEnIRwzUjSNh7SpbbgrG5GR_ZnrW_q2wpeR1xswKCJ2V2wX-jXg5FpDMmxEnpGnk5BsKJHxbIHmGTE74rND6i6kW_6Iy75zgd0wrZ7fTNcLclfgZWIumRD7ZDFercNLCJfG5lXSiT9muxlf priority: 102 providerName: ProQuest |
Title | Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40084870 https://journals.asm.org/doi/10.1128/msystems.01148-24 https://www.proquest.com/docview/3204298766 https://www.proquest.com/docview/3177156821 https://pubmed.ncbi.nlm.nih.gov/PMC12013275 https://doaj.org/article/c205cc8ad50c4643842bbd675fb0c6b2 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB_u9lDuRfw8q-cSQRCEnmmaNOmDyJ7ccSh3iriwbyVt0nPhttVtF9x3_3Anabu6svjgU6FJYZiPzkwm8xuAF1oWkdW6CHMrdMh5HocqLTBrLSOdRzLmWrtG4cur5GLK38_EbA-G8VY9A5udqZ2bJzVd3pz8-L5-iwb_pmuAUa8XHehxc-KD-5DxfThAx5S4XOyyj_b9kUsSS3RvfW1z55eHcJt7iHk3vHikmwXb8lce1n9XLPr3lco_fNT5XbjTB5dk0mnDPdiz1X241Y2bXD-An77bNnR9yA3RHo3ENqQuCQaB5HrVksW8g2VqNS4bsrAtqohrUm7IvCJD3zdxZ7ebxYKYdeO8o5NwqHtpW0Oc-rQ1UkJu3N0P0peCHsL0_OzLu4uwn8IQamRDGxpbcqOoKhXNpTKJQDaKkloj3MAympaaGsMjK4wrmcapFYVSmNUpmwqDv9r4EYyqurKPgaiUptJiiBcZB3ojdWQVlVblPJI6EXEALx3Ls0ELMp-hMJUNcsq8nDLGA3g1SCX71sFy_GvzqZPbZqND1PYv6uV11htoVjAqikJpI2jBMUxTnOW5wXSqzGmR5CyA40Hqv-mLmfPn6FCSAJ5vltFAXdVFV7Ze4Z5ISkySFYsCOOqUZEPJoGsBqC312SJ1e6Waf_Ug4BFzVTIpnvz_p0_hkLlpxpSHjB3DqF2u7DMMsdp8DPtyJsdwMJlMP37A5-nZ1afPY39gMfZG9Qv8iC8c |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiDeBAkYCISGFOo4dOweEKLTa0ocQaqXeUsd2ykpsUpqs0N75PfxGZvLYZRHqrdcdKxrtfPPyeGYIeWmUjbwxNsy9NKEQeRzq1ELWWkQmj1QsjMFG4YPDZHwsPp_IkzXye-iFwWeVg01sDbWrLN6Rb8YcTSfobvL-_EeIW6Owujqs0OhgsefnPyFlq9_tfgL5vuJ8Z_vo4zjstwqEBoLzJnS-EE4zXWiWK-0SCRGJLJh3EhdwsbQwzDkReemwBBinXlqtIUvRPpUOTEcM371G1gV2tI7I-tb24Zevy1udJFbgQfvyKdj-zWk3kbl-22YeIXbWj0w95St-sF0X8L8Y99-nmn_5vp3b5FYftNIPHcrukDVf3iXXuzWW83vkV9vFG2J_c01NO-XE17QqKASX9GzW0OmkG_fUGCA7OvUNQA-bn2s6KenQT07xTnhBtNTNa_S6iJzQ9CjyjiIsmwo4od_xTQntS0z3yfGVyOEBGZVV6R8RqlOWKg-hY-RwmI4ykddMeZ2LSJlExgF5jX951qtnnbWZD9fZIJysFU7GRUDeDFLJzrtxH5cd3kK5LQ7ipO72h-riLOsVP7OcSWu1cZJZAeGfFjzPHaRpRc5skvOAbAxSX_K3BHtAXizIoPhYzTGlr2ZwJlIKkm_No4A87ECy4ES0axIUC4hegc8Kq6uUcvKtHS4ecay-Kfn4cr6ekxvjo4P9bH_3cO8JuclxKzITIecbZNRczPxTCNWa_FmvH5ScXrVK_gErllT4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB7qFsUX8W606giKIMSdTGYykwcRa1taq0sRC32Lk5lJXXCT2mSRffdX-es8J5ddV6Rvfd0ZwmHPd25zboQ8N8pG3hgb5l6aUIg8DnVqIWotIpNHKhbGYKPwp0myfyw-nMiTDfJ76IXBsspBJ7aK2lUW38jHMUfVCbKbjIu-LOJoZ-_t2Y8QN0hhpnVYp9FB5NAvfkL4Vr852AFev-B8b_fL-_2w3zAQGnDUm9D5QjjNdKFZrrRLJHgnsmDeSVzGxdLCMOdE5KXDdGCcemm1hohF-1Q6UCMxfPcK2VRgFcWIbG7vTo4-r154kliBNe1TqWAHxrNuOnP9uo1CQuyyH5l6xtdsYrs64H_-7r9lm3_Zwb2b5EbvwNJ3HeJukQ1f3iZXu5WWizvkV9vRG2Kvc01NO_HE17QqKDia9HTe0Nm0G_3UGDh2dOYbgCE2Qtd0WtKht5zi-_Dy0FK3qNECI4pC0yPKO4oQbSqghH7H-hLap5vukuNL4cM9Miqr0j8gVKcsVR7cyMjhYB1lIq-Z8joXkTKJjAPyEv_yrBfVOmujIK6zgTlZy5yMi4C8GriSnXWjPy66vI18W17Eqd3tD9X5adYrgcxyJq3VxklmBbiCWvA8dxCyFTmzSc4DsjVwfUXfCvgBebY8BiWAmR1T-moOdyKlIBDXPArI_Q4kS0pEuzJBsYDoNfiskbp-Uk6_tYPGI46ZOCUfXkzXU3INRDH7eDA5fESuc1yQzETI-RYZNedz_xi8tiZ_0osHJV8vWyL_AMHcWSQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multi-omics+analyses+of+the+gut+microbiota+and+metabolites+in+children+with+metabolic+dysfunction-associated+steatotic+liver+disease&rft.jtitle=mSystems&rft.au=Du%2C+Landuoduo&rft.au=Zhang%2C+Kaichuang&rft.au=Liang%2C+Lili&rft.au=Yang%2C+Yi&rft.date=2025-04-22&rft.pub=American+Society+for+Microbiology&rft.eissn=2379-5077&rft.volume=10&rft.issue=4&rft_id=info:doi/10.1128%2Fmsystems.01148-24&rft_id=info%3Apmid%2F40084870&rft.externalDocID=PMC12013275 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-5077&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-5077&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-5077&client=summon |